FDA Inspection
EyePoint Pharmaceuticals, Inc.FDA Inspection 1230113 - EyePoint Pharmaceuticals, Inc. - February 15, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
This FDA Inspection record concerns EyePoint Pharmaceuticals, Inc., with an inspection on February 15, 2024, issued by the New England District Office, covering human drugs.
Open in Dashboard
ID · 96011f71-7dc7-4d1e-af2a-8fb571d5f403
Violation Codes7
21 CFR 211.100(b)21 CFR 211.110(a)21 CFR 211.113(b)21 CFR 211.186(a)21 CFR 211.19221 CFR 211.42(c)(10)(v)21 CFR 211.67(a)
Full citation text and observation details available on the Dashboard.